OICHARTS
8 AMThe 8 AM report →
HealthcareMedium impactAfter close

Dr Lal PathLabs Q3 FY26 net profit declines 6.4%

after close1 source ↓written by the desknot a recommendation

YoY for Q3
6.4%
rise in revenue
10.6%
in revenue
₹6,598 cr
Total income increased
10%
₹6,842 cr

Dr Lal PathLabs reported net profit ₹905 cr, down 6.4% YoY for Q3 FY26, despite a 10.6% rise in revenue to ₹6,598 cr. Total income increased 10% to ₹6,842 cr, while expenses rose 9.6% to ₹5,298 cr. The company declared an interim dividend of ₹3.5 per share, with the record date to be announced.

Shares were trading at ₹1,399.90, up 0.35% post-results.

Not investment advice. For informational purposes only.

OI Charts is not a SEBI-registered investment adviser or research analyst. This bulletin was written by the OI Charts desk from the public sources listed here. It is commentary on market conditions, not a basis for any investment decision and not a recommendation to buy or sell any security. Prices as of 30 Jan 2026, 16:08 IST.

Sourcesnews.google.com

Related